Evidence map›Paper›PMID 42403861›Full record

ArticleCureus2026

Molecular Evaluation of Rifampicin and Isoniazid Resistance in Pulmonary Tuberculosis Using Cartridge-Based Nucleic Acid Amplification Test and Line Probe Assay.

Rinku Yadav, Rosy Bala, Aparna Parmar, Parminder Singh, Aman Singh, Monika Sharma, Anshu Singh, Pawan Kalkal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rinku YadavMicrobiology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University) Mullana, Ambala, IND.
Rosy BalaMicrobiology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University) Mullana, Ambala, IND.
Aparna ParmarMicrobiology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, IND.
Parminder SinghMicrobiology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University) Mullana, Ambala, IND.
Aman SinghOrthopaedics, Adesh Medical College & Hospital, Mohri, IND.
Monika SharmaPharmacology, Pandit Neki Ram Sharma Government Medical College, Bhiwani, IND.
Anshu SinghMicrobiology, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND.
Pawan KalkalOncology, Positron Super Speciality and Cancer Hospital, Rohtak, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Pulmonary tuberculosis (TB) continues to be a major public health problem, especially with the rising number of drug-resistant TB cases. Rapid molecular tests such as cartridge-based nucleic acid amplification test (CB-NAAT) and line probe assay (LPA) help in the early diagnosis of TB and detection of drug resistance, allowing timely treatment and better disease control. Methods This cross-sectional study included 3451 pulmonary samples collected from patients suspected of having pulmonary tuberculosis. All samples were tested by CB-NAAT for detection of

Indexed as

drug-resistant tuberculosisisoniazid resistancekatg mutationline probe assay (lpa)multidrug-resistant tuberculosis (mdr-tb)rifampicin resistancerpob mutation

Identifiers

PMID42403861
PMCPMC13332706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.